Data as of Nov 21
| +0.13 / +0.08%|
The 19 analysts offering 12-month price forecasts for Amgen Inc have a median target of 173.00, with a high estimate of 196.00 and a low estimate of 130.00. The median estimate represents a +6.26% increase from the last price of 162.81.
The current consensus among 23 polled investment analysts is to Buy stock in Amgen Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.